Detalhe da pesquisa
1.
Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.
Antimicrob Agents Chemother
; 67(5): e0013223, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039666
2.
Trypanosoma cruzi 13C-labeled O-Glycan standards for mass spectrometry.
Glycobiology
; 29(4): 280-284, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30649355
3.
Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Infect Immun
; 84(9): 2627-38, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354447
4.
New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
J Infect Dis
; 209(1): 150-62, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23945371
5.
Evidence for the role of vacuolar soluble pyrophosphatase and inorganic polyphosphate in Trypanosoma cruzi persistence.
Mol Microbiol
; 90(4): 699-715, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24033456
6.
Frequency variation and dose modification of benznidazole administration for the treatment of Trypanosoma cruzi infection in mice, dogs and non-human primates.
bioRxiv
; 2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778432
7.
Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs.
J Vis Exp
; (184)2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815998
8.
Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure.
PLoS Negl Trop Dis
; 16(10): e0010688, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315597
9.
Oral exposure to Trypanosoma cruzi elicits a systemic CD8⺠T cell response and protection against heterotopic challenge.
Infect Immun
; 79(8): 3397-406, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628516
10.
Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs.
Microorganisms
; 9(2)2021 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33669310
11.
Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines.
Bioorg Med Chem
; 18(8): 2880-6, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20356752
12.
A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease.
Sci Transl Med
; 12(567)2020 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115952
13.
Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases.
Int J Parasitol Drugs Drug Resist
; 14: 17-27, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829099
14.
Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
Int J Antimicrob Agents
; 29(6): 733-7, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17395432
15.
Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
mBio
; 8(6)2017 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114029
16.
Weekly electrocardiographic pattern in mice infected with two different Trypanosoma cruzi strains.
Int J Cardiol
; 102(2): 211-7, 2005 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15982487
17.
Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage.
Int J Parasitol
; 32(7): 889-96, 2002 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12062560
18.
Potential new clinical therapies for Chagas disease.
Expert Rev Clin Pharmacol
; 7(3): 317-25, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716790
19.
Methodological advances in drug discovery for Chagas disease.
Expert Opin Drug Discov
; 6(6): 653-661, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712965
20.
Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA.
Expert Opin Drug Discov
; 6(9): 965-73, 2011 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22646217